1% Tirbanibulin Ointment for Actinic Keratoses on Upper Extremities: A Retrospective Case Review Study
DOI:
https://doi.org/10.2340/actadv.v103.15296Keywords:
Actinic keratosis, topical administration, upper extremity, treatment, efficacy, safetyAbstract
Abstract is missing (Short communication)
Downloads
References
Kaufmann R, Spelman L, Weightman W, Reifenberger J, Szeimies RM, Verhaeghe E, et al. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Br J Dermatol 2008; 158: 994-999.
https://doi.org/10.1111/j.1365-2133.2008.08488.x DOI: https://doi.org/10.1111/j.1365-2133.2008.08488.x
Ulrich M, Reinhold U, Dominicus R, Aschoff R, Szeimies RM, Dirschka T. Red light photodynamic therapy with BF-200 ALA showed superior efficacy in the treatment of actinic keratosis on the extremities, trunk, and neck in a vehicle-controlled phase III study. J Am Acad Dermatol 2021; 85: 1510-1519.
https://doi.org/10.1016/j.jaad.2021.03.031 DOI: https://doi.org/10.1016/j.jaad.2021.03.031
Abril-Pérez C, Mansilla-Polo M, Martin-Torregrosa D, Botella-Estrada R. Successful treatment of field of cancerization in the dorsum of the hands with 1% tirbanibulin ointment. Clin Exp Dermatol 2023; 48: 1048-1050.
https://doi.org/10.1093/ced/llad171 DOI: https://doi.org/10.1093/ced/llad171
Kempers S, DuBois J, Forman S, Poon A, Cutler E, Wang H, et al. Tirbanibulin ointment 1% as a novel treatment for actinic keratosis: phase 1 and 2 results. J Drugs Dermatol 2020; 19: 1093-1100.
https://doi.org/10.36849/JDD.2020.5576 DOI: https://doi.org/10.36849/JDD.2020.5576
Dao DPD, Sahni VN, Sahni DR, Balogh EA, Grada A, Feldman SR. 1% tirbanibulin ointment for the treatment of actinic keratoses. Ann Pharmacother 2022; 56: 494-500.
https://doi.org/10.1177/10600280211031329 DOI: https://doi.org/10.1177/10600280211031329
Gebauer K, Shumack S, Cowen PSJ. Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial. Br J Dermatol 2009; 161: 897-903.
https://doi.org/10.1111/j.1365-2133.2009.09260.x DOI: https://doi.org/10.1111/j.1365-2133.2009.09260.x
Berman B, Bhatia N, Piacquadio D, Houlihan A, Davidson D, Siegel D. Efficacy of aminolevulinic acid 20 % solution photodynamic therapy in the treatment of actinic keratoses on the upper extremities: a post hoc analysis of a phase 3, randomized, vehicle-controlled trial. Photodiagnosis Photodyn Ther 2020; 1; 32.
https://doi.org/10.1016/j.pdpdt.2020.102013 DOI: https://doi.org/10.1016/j.pdpdt.2020.102013
Miola AC, Ferreira ER, Lima TRR, Schmitt J V., Abbade LPF, Miot HA. Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial. Br J Dermatol 2018; 179: 1081-1087.
https://doi.org/10.1111/bjd.16824 DOI: https://doi.org/10.1111/bjd.16824
Kim YC, Yang JY, Yoon JS, Jo SJ, Ahn HH, Song KH, et al. A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT). Br J Dermatol 2018; 179: 836-843.
https://doi.org/10.1111/bjd.16368 DOI: https://doi.org/10.1111/bjd.16368
Angnardo L, Wolfe CM, Green WH, Cognetta AB. Comparison of Grenz ray and photodynamic therapy for field treatment of actinic keratoses on the forearm: a case series. Australas J Dermatol 2021; 62: 64-68.
https://doi.org/10.1111/ajd.13439 DOI: https://doi.org/10.1111/ajd.13439
Reinhold U, Hadshiew I, Melzer A, Prechtl A. Low-dose 5-fluorouracil in combination with salicylic acid for the treatment of actinic keratoses on the hands and/or forearms - results of a non-interventional study. J Eur Acad Dermatol Venereol 2017; 31: 455-462.
https://doi.org/10.1111/jdv.13935 DOI: https://doi.org/10.1111/jdv.13935
Brian Jiang SI, Kempers S, Rich P, Marcus S, Houlihan A, Piacquadio D, et al. A randomized, vehicle-controlled phase 3 study of aminolevulinic acid photodynamic therapy for the treatment of actinic keratoses on the upper extremities. Dermatol Surg 2019; 45: 890-897.
https://doi.org/10.1097/DSS.0000000000001760 DOI: https://doi.org/10.1097/DSS.0000000000001760
Gilaberte Y, Fernández-Figueras MT. Tirbanibulin: review of its novel mechanism of action and how it fits into the treatment of actinic keratosis. Actas Dermosifiliogr 2022; 113: 58-66. DOI: https://doi.org/10.1016/j.ad.2021.07.016
https://doi.org/10.1016/j.ad.2021.07.006 DOI: https://doi.org/10.1016/j.ad.2021.07.006
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Álvaro Iglesias-Puzas, Alberto Conde-Taboada, Lucía Campos-Muñoz, Ana Sirgado-Martínez, Eduardo López-Bran
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
